EWM
MRNA icon

Empirical Wealth Management’s Moderna MRNA Stock Holding History

Empirical Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,745
Closed -$207K – 596
2024
Q2 		$207K Buy
+1,745
New +$221K 0.01% 531
2024
Q1 		– Sell
-18,111
Closed -$1.8M – 545
2023
Q4 		$1.8M Sell
18,111
-1,227
-6% -$103K 0.06% 180
2023
Q3 		$2M Buy
19,338
+2,878
+17% +$321K 0.08% 155
2023
Q2 		$2M Buy
+16,460
New +$2.2M 0.08% 157
2021
Q4 		– Sell
-1,181
Closed -$455K – 530
2021
Q3 		$455K Sell
1,181
-11
-0.9% -$4.06K 0.03% 318
2021
Q2 		$280K Buy
+1,192
New +$213K 0.02% 380

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Empirical Wealth Management's MRNA Position: Q3 2024 in Review

Empirical Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,745 shares — an estimated $207K sold.

Empirical Wealth Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $2M in Q2 2023. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Empirical Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Empirical Wealth Management sold 1,745 Moderna shares in Q3 2024, an estimated $207K.
  • Empirical Wealth Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Empirical Wealth Management's Moderna position peaked at $2M in Q2 2023.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Empirical Wealth Management's 13F filing for Q3 2024, filed 1 Nov 2024.